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Metabolic risk associated with liver enzymes, uric acid,
and hemoglobin in adolescents
Sonimar de Souza1, Cézane P. Reuter 2, Lars B. Andersen3, Rodrigo A. Lima4, Karin A. Pfeiffer5, Elza D. de Mello6, Anelise R. Gaya7,
Silvia I. R. Franke2 and Jane D. P. Renner8
BACKGROUND: The associations of renal, hepatic, and hematologic markers with metabolic risk (MR) have already been shown in
adolescents. However, it is still controversial which marker best predicts metabolic changes in youth. The aim of this study was to
verify the association of MR with alanine aminotransferase (ALT), aspartate aminotransferase (AST), uric acid, and hemoglobin (Hb)
in adolescents.
METHODS: We evaluated 1713 Brazilian adolescents aged 10 to 17 years. MR was calculated using a continuous metabolic risk
score, including the sum of Z-scores of waist circumference, systolic blood pressure, fasting glucose, high-density lipoproteins,
triglycerides, and cardiorespiratory fitness. Cutoff points were set for MR prediction for five metabolic components (ALT, AST, AST/
ALT ratio, uric acid, and Hb).
RESULTS: MR was strongly associated with increased uric acid (odds ratio [OR]: 2.50; 95% confidence interval [CI]: 1.74–3.59), ALT
(OR: 2.64; 95% CI: 1.63–4.27), and AST levels (OR: 2.53; 95% CI: 1.24–5.18). Uric acid was shown to be the best predictor for MR
(sensitivity: 55.79%; specificity: 61.35%; area under the curve: 0.616).
CONCLUSION: Elevated hepatic, renal, and hematological markers were associated with MR in adolescents, especially ALT, AST, and
uric acid levels.
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IMPACT:
● Elevated hepatic, renal, and hematological markers were associated with metabolic risk in adolescents, especially ALT, AST, and
uric acid levels.
● It is still controversial which marker best predicts metabolic changes in adolescents. In addition, association of Hb with
metabolic risk is under-studied in this population.
● It is important to further investigate the relationship between elevated Hb and hepatic markers, since there are key aspects not
addressed yet. Our results highlight the importance of creating public health policies aimed to child and adolescent population,
to prevention of metabolic disorders from an early age.
INTRODUCTION
The increase in adolescent obesity rates and short- and long-term
complications of obesity emphasize the need for effective
prevention and treatment. Adolescence is a critical time period
during which to address obesity and its comorbidities, such as
metabolic risk (MR) because it is a primary time to develop
autonomy, yet adolescents have not reached maturity. For this
reason, early identification of diseases or metabolic changes are
important to prevent obesity and MR complications, as well as
liver and cardiovascular diseases.1,2 Continuous metabolic risk
score (cMetS) can be a viable marker to detect MR, since it is a
grouping of multiple cardiovascular risk factors that includes low
levels of cardiorespiratory fitness (CRF),3 high waist circumference
(WC), elevated systolic blood pressure (SBP), elevated triglycerides
(TGs), low levels of high-density lipoprotein cholesterol (HDL-c),
and elevated fasting glycemia.4
The clinical screening of MR by biological markers is important
and allows the prevention and monitoring of health status.5 One
set of biological markers that has shown importance for MR
includes renal, hepatic, and hematologic markers. For example, in
the United States, over the past 20 years, there has been an
increase in non-alcoholic fatty liver disease (NAFLD) in almost 11%
of adolescents. The presence of NAFLD was independent of body
mass index, considering that multiple factors may influence this
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condition.6 In Chinese, NAFLD was found in 9.3% of children and
adolescents, with NAFLD predominating in those who were
overweight and obese.7 Thus, examining specific biomarkers
related to hepatic, renal, and hematologic factors associated with
MR is important.
In this sense, earlier studies in Asian and American territories
found metabolic abnormalities through the Z-score of metabolic
syndrome (MetS) associated with liver changes in alanine
aminotransferase (ALT) and aspartate aminotransferase (AST)
enzymes.8,9 In addition, higher Z-score of MetS is related to
higher uric acid concentration in adolescents.10,11 Furthermore,
Chao et al.12 found associations of hepatic markers with
hemoglobin (Hb), in which high concentrations of Hb were
associated with cardiovascular dysfunction and an increase
in ALT. However, association of Hb with MR is under-studied in
adolescents and is unclear which indicator best predicts MR
in this population. Therefore, in the present study, we sought to
verify the association of MR with liver enzymes, uric acid, and Hb
in adolescents.
METHODS
The study population consisted of schoolchildren from public and
private schools from Santa Cruz do Sul, Rio Grande do Sul, Brazil.
A total of 1713 adolescents from 25 schools were surveyed,
covering the rural and urban areas (north, south, east, west, and
center) of the municipality. This study was based on a study called
“School Health – Phase III” (2014/2015), with evaluation of children
and adolescents aged 6–17 years, which was approved by the
Research Ethics Committee of the University of Santa Cruz do
Sul (UNISC) (protocol no. CAAE: 31576714.6.0000.5343; number:
714.216).
For this investigation, adolescents aged 10–17 years old
were included, and parents provided informed consent
and students 12 years or older signed the assent. We excluded
the students diagnosed with lung diseases, those who were
unable to perform the CRF test, those who were not fasting,
and those unable to perform the blood collection, as described
in Fig. 1.
The evaluations were carried out at the UNISC. For CRF
measurement, students completed a 6-min run/walk test on
outdoor athletic track, and the distance covered was obtained in
meters.13 For WC evaluation, the subjects remained in the
orthostatic position, with the use of a tape measure positioned
horizontally, surrounding the individual at the waist level at the
midpoint between the rib and the iliac crest.14 BP was determined
from the measurement with the students seated student after
resting for 5 min. A sphygmomanometer and stethoscope were
used on the right arm with a cuff suitable for the brachial
perimeter of the student, according to the parameters of the VII
Brazilian Hypertension Guidelines.15
For biochemical analysis, specialized personnel performed the
blood draws to obtain HDL-c, TG, ALT, AST, uric acid, and glucose.
Serum samples were evaluated on automated equipment Miura
200 (I.S.E., Rome, Italy) using commercial kits (DiaSys Diagnostic
Systems, Germany) and following the manufacturer’s recommen-
dations. For hepatic enzymes, the reference values of Lira et al.16
were considered (ALT >30 U/L and AST >37 U/L). For AST/ALT
ratio, <1 indicates NAFLD presence. Uric acid was determined by a
photometric enzymatic method and values were classified as
normal and hyperuricemia (>5.5 mg/dL).17 For the evaluation of
Hb levels, a whole blood sample was used in the automated
equipment Sysmex XS-800i, following the manufacturer’s instruc-
tions. The cutoff point for the definition of high Hb was according
to age and sex, using reference values for adolescents divided into
quartiles, being considered elevated when values >p75, for boys
(9–10 years: >13.17 g/dL; 11–12 years: >13.80 g/dL; 13–14 years:
14.40 g/dL; 15–17 years: 15.00 g/dL) and girls (9–10 years: >13.30
g/dL; 11–12 years: >13.47 g/dL; 13–14 years: 13.50 g/dL; 15–17
years: 13.40 g/dL).
MR was calculated using a cMetS by the sum of the Z-score of
the following parameters: WC, SBP, glucose, HDL-c, TG, and CRF, as
described by Reuter et al.4 Due to the inverse relationship with
MR, the HDL-c and CRF Z-score was multiplied by −1. We split the
population into four age groups and constructed Z-scores by age
group and sex. High values of cMetS indicate an undesirable
metabolic risk profile. The cutoff points for MR presence were
established at 3.40 for males and 3.61 for females (1.3 SD for boys
and 1.4 SD for girls).
General characteristics, such as age, sex, ethnicity, socio-
economic level, region, and zone of residence, were evaluated
by self-reported questionnaire. Tanner18 definition was used for
maturational stage evaluation, considering five stages: prepubertal
(stage I), initial development (stage II), continuous maturation
(stages III and IV), and matured (stage V). Adolescents were
instructed to fill the image corresponding to his current stage,
considering genital (for boys), breast development (for girls), and
pubic hair (for both). This evaluation was performed in a suitable
room, individually.
Data analysis was performed in the Statistical Package for
Social Sciences (SPSS), version 23.0 (IBM, Armonk, NY, USA). The
categorical data were expressed in absolute and relative
frequency. Analysis of variance (ANOVA) was applied to compare
the biochemical variables among students with and without MR.
Linear regression was performed to evaluate the association
between cMetS with AST, ALT, uric acid, and Hb. Logistic
regression was used to evaluate the association between the
outcome (MR presence) and the categorical independent variables
(AST, ALT, uric acid, Hb). Data were expressed as odds ratio (OR)
and 95% confidence interval (CI). All models were adjusted for sex,
age, ethnicity, and maturational stage. The cutoff points for MR,
using biochemical parameters, were established through sensitiv-
ity and specificity analysis, using the receiver operator character-
istic curve. For all the statistical tests used, significant differences
were considered for p < 0.05.
RESULTS
Table 1 shows the sample characteristics. Altered uric acid was
present in 14.7% of the adolescents, and values suggestive for
NAFLD were observed in 14.4%. The presence of MR was found in
13.6%, equally distributed between boys and girls (n= 92 for boys
and n= 141 for girls; p= 0.166; data not shown).
Adolescents with MR, compared to those adolescents without
MR, presented higher levels of uric acid (4.76 versus 4.22 mg/dL;
Population: 20,380 schoolchildren
(50 schools) from
Santa Cruz do Sul, RS, Brazil
2335
schoolchildren aged 6–17
years, from 25 public and private






•Children aged 6–9 years;
•Adolescents with pulmonary
diseases and/or who did not
perform some evaluation.
Fig. 1 Population and sample characteristics. Santa Cruz do Sul,
Rio Grande do Sul State, Brazil (2014–2015).
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p < 0.001), as well as high levels of ALT (19.05 versus 16.69 U/L;
p= 0.021) and Hb (13.48 versus 13.20 g/dL; p= 0.006) (Table 2).
When analyzing the continuous variables, a positive relationship
of cMetS with uric acid (β: 0.25 SD; p < 0.001), ALT (β: 0.10 SD; p <
0.001) and AST (β: 0.05 SD; p= 0.042) in adolescents was observed
(Table 3).
For categorical variables, elevated concentration of all biological
markers was associated with MR (Table 4). ALT (OR: 2.64; 95% CI:
1.63–4.27), AST (OR: 2.53; 95% CI: 1.24–5.18), and uric acid (OR:
2.50; 95% CI: 1.74–3.59) showed highest OR.
Cutoff points were set for MR prediction, considering five
metabolic components. Uric acid was shown to be the best MR
predictor (sensitivity: 55.79%; specificity: 61.35% and AUC: 0.616),
establishing cutoff points at 5.64 for males and 4.45 for females.
For AST, ALT, AST/ALT, and Hb cutoff points, low specificity and
sensitivity were found (Table 5).
DISCUSSION
We found a positive relationship between uric acid levels and
cMetS. Adolescents with elevated uric acid levels had a higher
prevalence of MR. In addition, adolescents with MR presented
higher levels of uric acid when compared to those adolescents
with the absence of MR. In Mexican children, a positive relation-
ship between uric acid levels and cMetS has been observed. In
Table 1. Description of sample characteristics.


























High (A–B) 726 (42.4)
Medium (C) 921 (53.8)
Low (D–E) 66 (3.9)
Uric acid
Normal 1461 (85.3) 4.29 (1.4)
Elevated (>5.5mg/dL) 252 (14.7)
AST
Normal 1670 (97.5) 22.1 (6.7)
Elevated (>37 U/L) 43 (2.5)
ALT
Normal 1614 (94.2) 17.1 (8.9)
Elevated (>30 U/L) 99 (5.8)
AST/ALT
≥1 1467 (85.6) 1.4 (0.56)
<1 (NAFLD suggestive) 246 (14.4)
Hemoglobin
Low/normal 1256 (73.3) 13.2 (1.4)
Elevated (>p75) 457 (26.7)
Metabolic risk
Absence 1052 (86.3) −0.0 (2.6)
Presence (sum of Z-scores >1.3 SD for
boys/1.4 SD for girls)
233 (13.6)
Santa Cruz do Sul, RS, Brazil (2014–2015).
Maturational stage: I, prepubertal; II, initial development; III and IV,
continuous maturation; V, mature.
AST aspartate aminotransferase, ALT alanine aminotransferase, NAFLD non-
alcoholic fatty liver disease, Hb hemoglobin, SD standard deviation.
Table 2. Comparison of mean values of uric acid, hepatic markers, and
hemoglobin in adolescents with and without metabolic risk.
Metabolic risk p Value
Absence (n= 1052) Presencea (n= 233)
Uric acid (mg/dL) 4.22 (1.35) 4.76 (1.37) <0.001
AST (U/L) 22.01 (6.39) 23.10 (8.32) 0.021
ALT (U/L) 16.69 (7.39) 19.05 (11.37) <0.001
AST/ALT 1.46 (0.57) 1.39 (0.56) 0.070
Hb (g/dL) 13.20 (1.26) 13.48 (2.28) 0.006
Values are expressed as mean (standard deviation).
ANOVA analysis of variance, AST aspartate aminotransferase, ALT alanine
aminotransferase.
acMetS: >1.3 SD for boys and >1.4 SD for girls.
Table 3. Association between uric acid, hepatic markers, and
hemoglobin with continuous score for metabolic syndrome in
adolescents.
Continuous score for metabolic syndrome





0.47 (0.38; 0.57) 0.05 0.25 <0.001
AST (U/L) 0.02 (0.00; 0.04) 0.01 0.05 0.042
ALT (U/L) 0.03 (0.2; 0.05) 0.01 0.10 <0.001
AST/ALT −0.18 (−0.4; 0.04) 0.11 −0.04 0.118
Hb (g/dL) 0.06 (−0.03; 0.15) 0.05 0.03 0.194
Linear regression. Models adjusted for sex, age, ethnicity, and
maturational stage.
SE standard error, AST aspartate aminotransferase, ALT alanine
aminotransferase.
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China, a 10-year prospective study with adolescents showed
that boys with high uric acid levels were at increased risk of
hypertension and MetS.19 However, few studies have evaluated
the association of uric acid with cMetS in adolescents, especially in
Brazil.
The presence of MR in our study was also associated with
elevated ALT levels. Adolescents with MR showed the presence of
suggestive NAFLD. It is noteworthy that increased uric acid levels
contribute to alterations of other metabolic parameters in obese
students, especially in association with altered ALT.11 It has been
shown that cMetS was a useful marker in the identification of
youngsters with high levels of ALT and possible NAFLD, with
excess weight being an aggravating factor in cMetS values.8 It
seems that altered metabolic parameters (overweight/obesity,
elevated WC, and altered SBP, as well elevated levels of uric acid
and blood lipids) were strongly associated with hepatic alterations
(elevated ALT), which suggests NAFLD.7
For Korean adolescents, sex-adjusted ALT values were a valid
marker of possible NAFLD. Many factors may contribute to the
relatively high prevalence of suspected NAFLD in schoolchildren,
such as lifestyle. In the current study, the relationships of elevated
levels of ALT, AST, and AST/ALT with MR factors were independent
of anthropometric indices. Therefore, liver enzymes can be
considered to contribute to the development of MR factor during
childhood and an additional component of MetS.20 Lee and Yang9
found high sensitivity (100%) for ALT, AST, and AST/ALT ratio for
predicting MR in Korean girls, with also high specificity, especially
for ALT (67.2%) and AST/ALT ratio (61.1%).
When establishing cutoff points for cMetS in adolescents, uric
acid presents higher sensitivity and specificity for MR presence,
compared to AST, ALT, AST/ALT, and Hb. Low sensitivity and
specificity were observed for boys in ALT and Hb, as well for ALT
and AST/ALT for both sexes. It seems that uric acid in adolescents
is a good predictor for MetS since it has been shown in the current
study and also previously.21 Moreover, uric acid was a good
predictor of hypertension in a 10 years follow-up study.19
Our study has some limitations that should be mentioned. First,
this is a cross-sectional study, which limits the extrapolation of our
results. Ideally, the associations should be evaluated in a longitudinal
setting. Second, the study was conducted in the southern region of
Brazil, and there are important ethnic differences when comparing
to other regions of the country. Finally, we used hepatic enzymes to
Table 4. Association between uric acid, hepatic markers, and
hemoglobin with the presence of metabolic risk in adolescents.




Elevated 2.50 (1.74–3.59) <0.001
AST
Normal 1
Elevated 2.53 (1.24–5.18) 0.011
ALT
Normal 1
Elevated 2.64 (1.63–4.27) <0.001
AST/ALT
≥1 1
<1 (NAFLD suggestive) 1.55 (1.08–2.23) 0.018
Hb
Low/normal 1
Elevated 1.54 (1.14–2.08) 0.005
Logistic regression for metabolic risk as a dependent variable
(presence versus absence). Analysis adjusted for sex, age, ethnicity, and
maturational stage.
AST aspartate aminotransferase, ALT alanine aminotransferase, NAFLD non-
alcoholic fatty liver disease, OR odds ratio, CI confidence interval.
Table 5. Cutoff points for uric acid, hepatic markers, and hemoglobin
for the presence of metabolic risk in adolescents.
All Male Female
Uric acid (mg/dL)
Cutoff points >4.44 >5.64 >4.45

















AUC 0.616 0.641 0.618
p Value* <0.001 <0.001 <0.001
AST (U/L)
Cutoff points >21.29 >21.42 >23.00

















AUC 0.530 0.558 0.524
p Value* 0.137 0.056 0.359
ALT (U/L)
Cutoff points >16.27 >16.88 >22.35

















AUC 0.553 0.588 0.535
p Value* 0.010 0.005 0.194
AST/ALT
Cutoff points ≤1.39 ≤1.05 ≤1.52

















AUC 0.542 0.562 0.523
p Value* 0.043 0.069 0.385
Hb (g/dL)
Cutoff points >13.20 >13.40 >12.70

















AUC 0.535 0.577 0.528
p Value* 0.089 0.018 0.283
ROC receiver operating characteristic curve, AUC area under the curve,
CI confidence interval, AST aspartate aminotransferase, ALT alanine
aminotransferase, Hb hemoglobin.
*Significant values for p < 0.05.
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analyze the presence of suggestive NAFLD, and assessing hepatic
enzymes with ultrasonography would provide more accurate
estimates. Therefore, we emphasize that the conclusions of our
study should be interpreted with caution.
The results indicate that elevated hepatic, renal, and hemato-
logical markers were associated with MR in adolescents, especially
ALT, AST, and uric acid levels. Future work should focus on the
development of cutoff points for AST, NAFLD, and Hb and their
association with metabolic disorders, obesity, and low levels of
CRF, identifying the mechanisms of those components in relation
to MR. It is important to further investigate the relationship
between elevated Hb and hepatic markers, since there are key
aspects not addressed yet. Another important aspect would be to
investigate these relationships in various ethnic groups and blood
types, to better understand the metabolic disorders and the
different characteristics by specific groups. Our results, however,
highlight the importance of creating public health policies aimed
to child and adolescent population, to prevention of metabolic
disorders from an early age.
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